Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
side by side viewer icon HTML

Abstract

Antimicrobial Resistance (AMR) poses a critical threat to global health, contributing to increased morbidity, mortality, and substantial economic burden. This review highlights the profound clinical and financial consequences of infections caused by multidrug-resistant (MDR) bacteria. Of particular concern is the escalation of bacterial resistance linked to the indiscriminate use of antibiotics during the COVID-19 pandemic, which could lead to increased mortality rates. Additionally, this article emphasizes the significance of Antimicrobial Stewardship (AMS), which is a healthcare strategy aiming to encourage, develop, monitor, and assess the sensible use of antimicrobials in order to protect their long-term success. Consequently, it highlights the value and effects of an Antimicrobial Stewardship Program (ASP) in combating resistance and protecting global health.

Furthermore, the necessity of adopting a holistic “One Health” approach, an integrative, multisectoral strategy, is discussed as essential in addressing the growing AMR crisis. The review advocates for evidence-based policies that support the “One Health” framework, enhance immunization programs, educate healthcare professionals, and raise public awareness about AMR. This article provides a comprehensive overview of the scale, consequences, and potential solutions to AMR, urging collaborative efforts across sectors and stringent measures to combat this global health challenge.

2024 © 2024 The Author(s). Published by Bentham Science Publisher. The Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882352704250127093311
2024-01-01
2025-09-28

  • From This Site

    /content/journals/nemj/10.2174/0102506882352704250127093311
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/5/1/NEMJ-5-E02506882352704.html?itemId=/content/journals/nemj/10.2174/0102506882352704250127093311&mimeType=html&fmt=ahah

References

  1. SifriZ. ChokshiA. CennimoD. HorngH. Global contributors to antibiotic resistance.J. Glob. Infect. Dis.2019111364210.4103/jgid.jgid_110_1830814834
     [Google Scholar]
  2. DeliaS.C. Practice. Misuse of antibiotics and the dissemination of antibiotic resistant bacteria in the community.MCAST J. Appl. Res. Pract.2020419110610.5604/01.3001.0014.4400
     [Google Scholar]
  3. ChenJ. SidibiA.M. ShenX. DaoK. MaigaA. XieY. HeskethT. Lack of antibiotic knowledge and misuse of antibiotics by medical students in Mali: A cross-sectional study.Expert Rev. Anti Infect. Ther.202119679780410.1080/14787210.2021.185773133251896
     [Google Scholar]
  4. MallahN. OrsiniN. FigueirasA. TakkoucheB. ControlI. Education level and misuse of antibiotics in the general population: A systematic review and dose–response meta-analysis.Antimicrob. Resist. Infect. Control20221112410.1186/s13756‑022‑01063‑535115030
     [Google Scholar]
  5. MurrayC.J.L. IkutaK.S. ShararaF. SwetschinskiL. AguilarR.G. GrayA. HanC. BisignanoC. RaoP. WoolE. JohnsonS.C. BrowneA.J. ChipetaM.G. FellF. HackettS. Haines-WoodhouseG. HamadaniK.B.H. KumaranE.A.P. McManigalB. AchalapongS. AgarwalR. AkechS. AlbertsonS. AmuasiJ. AndrewsJ. AravkinA. AshleyE. BabinF-X. BaileyF. BakerS. BasnyatB. BekkerA. BenderR. BerkleyJ.A. BethouA. BielickiJ. BoonkasidechaS. BukosiaJ. CarvalheiroC. Castañeda-OrjuelaC. ChansamouthV. ChaurasiaS. ChiurchiùS. ChowdhuryF. DonatienC.R. CookA.J. CooperB. CresseyT.R. Criollo-MoraE. CunninghamM. DarboeS. DayN.P.J. LucaD.M. DokovaK. DramowskiA. DunachieS.J. BichD.T. EckmannsT. EibachD. EmamiA. FeaseyN. Fisher-PearsonN. ForrestK. GarciaC. GarrettD. GastmeierP. GirefA.Z. GreerR.C. GuptaV. HallerS. HaselbeckA. HayS.I. HolmM. HopkinsS. HsiaY. IregbuK.C. JacobsJ. JarovskyD. JavanmardiF. JenneyA.W.J. KhoranaM. KhusuwanS. KissoonN. KobeissiE. KostyanevT. KrappF. KrumkampR. KumarA. KyuH.H. LimC. LimK. LimmathurotsakulD. LoftusM.J. LunnM. MaJ. ManoharanA. MarksF. MayJ. MayxayM. MturiN. Munera-HuertasT. MusichaP. MusilaL.A. Mussi-PinhataM.M. NaiduR.N. NakamuraT. NanavatiR. NangiaS. NewtonP. NgounC. NovotneyA. NwakanmaD. ObieroC.W. OchoaT.J. Olivas-MartinezA. OlliaroP. OokoE. Ortiz-BrizuelaE. OunchanumP. PakG.D. ParedesJ.L. PelegA.Y. PerroneC. PheT. PhommasoneK. PlakkalN. Ponce-de-LeonA. RaadM. RamdinT. RattanavongS. RiddellA. RobertsT. RobothamJ.V. RocaA. RosenthalV.D. RuddK.E. RussellN. SaderH.S. SaengchanW. SchnallJ. ScottJ.A.G. SeekaewS. SharlandM. ShivamallappaM. Sifuentes-OsornioJ. SimpsonA.J. SteenkesteN. StewardsonA.J. StoevaT. TasakN. ThaiprakongA. ThwaitesG. TigoiC. TurnerC. TurnerP. Doornv.H.R. VelaphiS. VongpradithA. VongsouvathM. VuH. WalshT. WalsonJ.L. WanerS. WangrangsimakulT. WannapinijP. WozniakT. SharmaY.T.E.M.W. YuK.C. ZhengP. SartoriusB. LopezA.D. StergachisA. MooreC. DolecekC. NaghaviM. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis.Lancet20223991032562965510.1016/S0140‑6736(21)02724‑035065702
     [Google Scholar]
  6. MorrisonL. ZembowerT.R. Antimicrobial resistance.Gastrointest. Endosc. Clin. N. Am.202030461963510.1016/j.giec.2020.06.00432891221
     [Google Scholar]
  7. MajumderM.A.A. RahmanS. CohallD. BharathaA. SinghK. HaqueM. HilaireG.S.M. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health.Infect. Drug Resist.2020134713473810.2147/IDR.S29083533402841
     [Google Scholar]
  8. SagaT. YamaguchiK.J.J. History of antimicrobial agents and resistant bacteria.Japan Med. Assoc. J.2009522103108
     [Google Scholar]
  9. StefaniS. ChungD.R. LindsayJ.A. FriedrichA.W. KearnsA.M. WesthH. MacKenzieF.M. Meticillin-resistant Staphylococcus aureus (MRSA): Global epidemiology and harmonisation of typing methods.Int. J. Antimicrob. Agents201239427328210.1016/j.ijantimicag.2011.09.03022230333
     [Google Scholar]
  10. Velazquez-MezaM.E. Galarde-LópezM. Carrillo-QuirózB. Alpuche-ArandaC.M. Antimicrobial resistance: One health approach.Vet. World202215374374910.14202/vetworld.2022.743‑74935497962
     [Google Scholar]
  11. KnightG.M. GloverR.E. McQuaidC.F. OlaruI.D. GallandatK. LeclercQ.J. FullerN.M. WillcocksS.J. HasanR. Kleefv.E. ChandlerC.I.R. Antimicrobial resistance and COVID-19: Intersections and implications.eLife202110e6413910.7554/eLife.6413933588991
     [Google Scholar]
  12. GhoshS. BornmanC. ZaferM.M. Antimicrobial resistance threats in the emerging covid-19 pandemic: Where do we stand?J. Infect. Pub. Health.202114555556010.1016/j.jiph.2021.02.01133848884
     [Google Scholar]
  13. LaiC.C. ChenS.Y. KoW.C. HsuehP.R. Increased antimicrobial resistance during the COVID-19 pandemic.Int. J. Antimicrob. Agents202157410632410.1016/j.ijantimicag.2021.10632433746045
     [Google Scholar]
  14. KhoujaT. MitsantisukK. TadrousM. SudaK.J. Global consumption of antimicrobials: Impact of the WHO global action plan on antimicrobial resistance and 2019 coronavirus pandemic (COVID-19).J. Antimicrob. Chemother.20227751491149910.1093/jac/dkac02835178565
     [Google Scholar]
  15. MahmoudiHJGh Bacterial co-infections and antibiotic resistance in patients with COVID-19.GMS Hyg. Infect. Cont.202015Doc35
     [Google Scholar]
  16. ObeidatH. El-nasserZ. AmarinZ. QablanA. GharaibehF. The impact of COVID-19 pandemic on healthcare associated infections: A teaching hospital experience.Medicine (Baltimore)202310215e3348810.1097/MD.000000000003348837058033
     [Google Scholar]
  17. DespotovicA. MilosevicB. CirkovicA. VujovicA. CucanicK. CucanicT. StevanovicG. The impact of COVID-19 on the profile of hospital-acquired infections in adult intensive care units.Antibiotics20211010114610.3390/antibiotics1010114634680727
     [Google Scholar]
  18. ZeshanB. KarobariM.I. AfzalN. SiddiqA. BashaS. BasheerS.N. PeeranS.W. MustafaM. DaudN.H.A. AhmedN. YeanC.Y. NooraniT.Y. The usage of antibiotics by COVID-19 patients with comorbidities: The risk of increased antimicrobial resistance.Antibiotics20211113510.3390/antibiotics1101003535052912
     [Google Scholar]
  19. CarusoP MaiorinoMI MaceraM SignorielloG CastellanoL ScappaticcioL Antibiotic resistance in diabetic foot infection: How it changed with COVID-19 pandemic in a tertiary care center.Diabet. Res. Clin. Pract.2021175108797
     [Google Scholar]
  20. NorrbyS. NordC. FinchR. Lack of development of new antimicrobial drugs: A potential serious threat to public health.Lancet Infect. Dis.20055211511910.1016/S1473‑3099(05)70086‑415680781
     [Google Scholar]
  21. ChengG. DaiM. AhmedS. HaoH. WangX. YuanZ. Antimicrobial drugs in fighting against antimicrobial resistance.Front. Microbiol.2016747010.3389/fmicb.2016.0047027092125
     [Google Scholar]
  22. ChengG. HaoH. XieS. WangX. DaiM. HuangL. YuanZ. Antibiotic alternatives: The substitution of antibiotics in animal husbandry?Front. Microbiol.2014521710.3389/fmicb.2014.0021724860564
     [Google Scholar]
  23. ChahineE.B. DoughertyJ.A. ThornbyK.A. GuirguisE.H. Antibiotic approvals in the last decade: Are we keeping up with resistance?Ann. Pharmacother.202256444146210.1177/1060028021103139034259076
     [Google Scholar]
  24. AndreiS. DrocG. StefanG. FDA approved antibacterial drugs: 2018-2019.Discoveries201974e10210.15190/d.2019.1532309620
     [Google Scholar]
  25. World Health Organization BJWHOGSwitzerlandNo time to wait: Securing the future from drug-resistant infections.2019
     [Google Scholar]
  26. DuvalR.E. GrareM. DemoréB. Fight against antimicrobial resistance: We always need new antibacterials but for right bacteria.Molecules20192417315210.3390/molecules2417315231470632
     [Google Scholar]
  27. LiuY.Y. WangY. WalshT.R. YiL.X. ZhangR. SpencerJ. DoiY. TianG. DongB. HuangX. YuL.F. GuD. RenH. ChenX. LvL. HeD. ZhouH. LiangZ. LiuJ.H. ShenJ. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study.Lancet Infect. Dis.201616216116810.1016/S1473‑3099(15)00424‑726603172
     [Google Scholar]
  28. DolejskaM. PapagiannitsisC.C. Plasmid-mediated resistance is going wild.Plasmid2018999911110.1016/j.plasmid.2018.09.01030243983
     [Google Scholar]
  29. MillanS.A. Evolution of plasmid-mediated antibiotic resistance in the clinical context.Trends Microbiol.2018261297898510.1016/j.tim.2018.06.00730049587
     [Google Scholar]
  30. SkovR.L. MonnetD.L. Plasmid-mediated colistin resistance (mcr-1 gene): Three months later, the story unfolds.Euro. Surveill.20162193015510.2807/1560‑7917.ES.2016.21.9.3015526967914
     [Google Scholar]
  31. RezaN. GeradaA. StottK.E. HowardA. SharlandM. HopeW. Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: Implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing.Clin. Microbiol. Rev.2024372e00139-2310.1128/cmr.00139‑2338436564
     [Google Scholar]
  32. RiceL.B. Antimicrobial stewardship and antimicrobial resistance.Med. Clin. North Am.2018102580581810.1016/j.mcna.2018.04.00430126572
     [Google Scholar]
  33. WhiteA. HughesJ.M. Critical importance of a one health approach to antimicrobial resistance.EcoHealth201916340440910.1007/s10393‑019‑01415‑531250160
     [Google Scholar]
  34. WrightG.D. Antibiotic adjuvants: Rescuing antibiotics from resistance.Trends Microbiol.2016241186287110.1016/j.tim.2016.06.00927430191
     [Google Scholar]
  35. BernalP. Molina-SantiagoC. DaddaouaA. LlamasM.A. Antibiotic adjuvants: Identification and clinical use.Microb. Biotechnol.20136544544910.1111/1751‑7915.1204423445397
     [Google Scholar]
  36. LauCSM ChamberlainRS Probiotics are effective at preventing Clostridium difficile-associated diarrhea: A systematic review and meta-analysis.Int. J. Gen. Med.201692737
     [Google Scholar]
  37. OhlC.A. LutherV.P. Antimicrobial stewardship for inpatient facilities.J. Hosp. Med.20116S1Suppl. 1S4S1510.1002/jhm.88121225949
     [Google Scholar]
  38. DoronS. DavidsonL.E. Antimicrobial stewardship. Mayo Clinic Proceedings.New YorkElsevier2011
     [Google Scholar]
  39. EwersT. KnoblochM.J. SafdarN. Safdar NJCTOiID. Antimicrobial stewardship: The role of the patient.Curr. Treat. Options Infect. Dis.2017919210310.1007/s40506‑017‑0106‑z
     [Google Scholar]
  40. JonesA.S. IsaacR.E. PriceK.L. PlunkettA.C. Plunkett ACJPq, safety. Impact of positive feedback on antimicrobial stewardship in a pediatric intensive care unit: A quality improvement project.Pediatr. Qual. Saf.201945e20610.1097/pq9.000000000000020631745509
     [Google Scholar]
  41. KakiR. ElligsenM. WalkerS. SimorA. PalmayL. DanemanN. Impact of antimicrobial stewardship in critical care: A systematic review.J. Antimicrob. Chemother.20116661223123010.1093/jac/dkr13721460369
     [Google Scholar]
  42. MorrisA.M. Antimicrobial stewardship programs: Appropriate measures and metrics to study their impact.Curr. Treat. Options Infect. Dis.20146210111210.1007/s40506‑014‑0015‑325999798
     [Google Scholar]
  43. NathwaniD. VargheseD. StephensJ. AnsariW. MartinS. CharbonneauC. Value of hospital antimicrobial stewardship programs [ASPs]: A systematic review.Antimicrob. Resist. Infect. Control2019813510.1186/s13756‑019‑0471‑030805182
     [Google Scholar]
  44. Magnano San LioR. FavaraG. MaugeriA. BarchittaM. AgodiA. Agodi AJIjoer, health p. How antimicrobial resistance is linked to climate change: An overview of two intertwined global challenges.Int. J. Environ. Res. Public Health2023203168110.3390/ijerph2003168136767043
     [Google Scholar]
  45. MacFaddenD.R. McGoughS.F. FismanD. SantillanaM. BrownsteinJ.S. Antibiotic resistance increases with local temperature.Nat. Clim. Chang.20188651051410.1038/s41558‑018‑0161‑630369964
     [Google Scholar]
  46. HayesC. EleyC. BrownC. SyedaR. VerlanderN.Q. HannM. McNultyC. Improving educator’s knowledge and confidence to teach infection prevention and antimicrobial resistance.Health Educ. J.202180213114410.1177/0017896920949597
     [Google Scholar]
  47. OrganizationW.H. Health workers’ education and training on antimicrobial resistance: Curricula guide.Geneva, SwitzerlandWorld Health Organization2019
     [Google Scholar]
  48. Rogers Van KatwykS. JonesS.L. HoffmanS.J. Mapping educational opportunities for healthcare workers on antimicrobial resistance and stewardship around the world.Hum. Resour. Health2018161910.1186/s12960‑018‑0270‑3
     [Google Scholar]
  49. MajumderM.A.A. SinghK. HilaireM.G.S. RahmanS. SaB. HaqueM. Haque MJEroa-it. Tackling antimicrobial resistance by promoting antimicrobial stewardship in medical and allied health professional curricula.Exp. Rev. Anti. Infect. Ther.202018121245125810.1080/14787210.2020.179663832684048
     [Google Scholar]
  50. MaillardJ.Y. BloomfieldS.F. CourvalinP. EssackS.Y. GandraS. GerbaC.P. RubinoJ.R. ScottE.A. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper.Am. J. Infect. Cont.20204891090109910.1016/j.ajic.2020.04.01132311380
     [Google Scholar]
  51. BoccabellaL. PalmaE.G. AbenavoliL. ScarlataG.G.M. BoniM. IaniroG. SantoriP. TackJ.F. ScarpelliniE. Post-coronavirus disease 2019 pandemic antimicrobial resistance.Antibiotics202413323310.3390/antibiotics1303023338534668
     [Google Scholar]
  52. MallickJS NairP AbbewET DeunV.A Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: A systematic review.J. Antimicro. Resist.202242dlac029
     [Google Scholar]
  53. NguyenT.V.A. AnthonyR.M. BañulsA.L. NguyenT.V.A. VuD.H. AlffenaarJ.W.C. Bedaquiline resistance: Its emergence, mechanism, and prevention.Clin. Infect. Dis.201866101625163010.1093/cid/cix99229126225
     [Google Scholar]
  54. IarikovD. WasselR. FarleyJ. NambiarS. Nambiar SJId, therapy. Adverse events associated with fosfomycin use: Review of the literature and analyses of the FDA adverse event reporting system database.Infect. Dis. Ther.20154443345810.1007/s40121‑015‑0092‑826437630
     [Google Scholar]
  55. LimL.M. LyN. AndersonD. YangJ.C. MacanderL. JarkowskiA.III ForrestA. BulittaJ.B. TsujiB.T. Resurgence of colistin: A review of resistance, toxicity, pharmacodynamics, and dosing.Pharmacotherapy201030121279129110.1592/phco.30.12.127921114395
     [Google Scholar]
  56. PokharelS. AdhikariB. Antimicrobial resistance and over the counter use of drugs in Nepal.J. Glob. Health202010101036010.7189/jogh.10.01036032566152
     [Google Scholar]
  57. World Health Organization (WHO). Global research agenda for antimicrobial resistance in human health.2023Available from: https://www.who.int/publications/m/item/global-research-agenda-for-antimicrobial-resistance-in-human-health
  58. VázquezR. Rivero-BucetaV. Campod.R. Poblete-CastroI. HerenciasC. Editorial: Advanced technologies in bioengineering to fight antimicrobial resistance.Front. Bioeng. Biotechnol.202311118246310.3389/fbioe.2023.118246337051273
     [Google Scholar]
  59. Martin-LoechesI. DaleG.E. TorresA. Murepavadin: A new antibiotic class in the pipeline.Expert Rev. Anti Infect. Ther.201816425926810.1080/14787210.2018.144102429451043
     [Google Scholar]
  60. Díez-AguilarM. EkkelenkampM. MorosiniM.I. HuertasN. Campod.R. ZamoraJ. FluitA.C. TunneyM.M. ObrechtD. BernardiniF. CantónR. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.J. Antimicrob. Chemother.202176102578258510.1093/jac/dkab22234283223
     [Google Scholar]
  61. WheelerN.E. PriceV. Cunningham-OakesE. TsangK.K. NunnJ.G. MidegaJ.T. AnjumM.F. WadeM.J. FeaseyN.A. PeacockS.J. JauneikaiteE. BakerK.S. Innovations in genomic antimicrobial resistance surveillance.Lancet Microbe.2023412e1063e107010.1016/S2666‑5247(23)00285‑937977163
     [Google Scholar]
  62. LinD.M. KoskellaB. LinH.C. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.World J. Gastrointest. Pharmacol. Ther.20178316217310.4292/wjgpt.v8.i3.16228828194
     [Google Scholar]
  63. GórskiA. MiędzybrodzkiR. WęgrzynG. Jończyk-MatysiakE. BorysowskiJ. Weber-DąbrowskaB. Phage therapy: Current status and perspectives.Med. Res. Rev.202040145946310.1002/med.2159331062882
     [Google Scholar]
  64. SuhG.A. LodiseT.P. TammaP.D. KniselyJ.M. AlexanderJ. AslamS. BartonK.D. BizzellE. TottenK.M.C. CampbellJ.L. ChanB.K. CunninghamS.A. GoodmanK.E. Greenwood-QuaintanceK.E. HarrisA.D. HesseS. MaressoA. NussenblattV. PrideD. RybakM.J. SundZ. Duinv.D. TyneV.D. PatelR. Considerations for the use of phage therapy in clinical practice.Antimicrob. Agents Chemother.2022663e02071-2110.1128/aac.02071‑2135041506
     [Google Scholar]
  65. ChowdhuryA.S. CallD.R. BroschatS.L. PARGT: A software tool for predicting antimicrobial resistance in bacteria.Sci. Rep.20201011103310.1038/s41598‑020‑67949‑932620856
     [Google Scholar]
  66. ImchenM. MoopantakathJ. KumavathR. BarhD. TiwariS. GhoshP. AzevedoV. Current trends in experimental and computational approaches to combat antimicrobial resistance.Front. Genet.20201156397510.3389/fgene.2020.56397533240317
     [Google Scholar]
  67. TunstallT. PortelliS. PhelanJ. ClarkT.G. AscherD.B. FurnhamN. Combining structure and genomics to understand antimicrobial resistance.Comput. Struct. Biotechnol. J.2020183377339410.1016/j.csbj.2020.10.01733294134
     [Google Scholar]
  68. PiddockL.J.V. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?J. Antimicrob. Chemother.201570102679268010.1093/jac/dkv17526089440
     [Google Scholar]
  69. LloydD.G. SchofieldB.J. GoddardM.R. TaylorE.J. Chemotherapy. De novo resistance to Arg10-teixobactin occurs slowly and is costly.Antimicrob. Agents Chemother.2020651e01152-2010.1128/AAC.01152‑2033046494
     [Google Scholar]
  70. DeepikaJ ShettyAC Deciphering teixobactin resistance mechanisms in enterococcus faecalis through integrated rna-seq and hub genes identification.Res. Sq. Platform.202416
     [Google Scholar]
  71. MicoliF. BagnoliF. RappuoliR. SerrutoD. The role of vaccines in combatting antimicrobial resistance.Nat. Rev. Microbiol.202119528730210.1038/s41579‑020‑00506‑333542518
     [Google Scholar]
  72. NIHR Global Health Research Unit on Genomic Surveillance of AMR Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: A roadmap.BMJ Glob. Health2020511e00224410.1136/bmjgh‑2019‑00224433239336
     [Google Scholar]
  73. GordonN.C. PriceJ.R. ColeK. EverittR. MorganM. FinneyJ. KearnsA.M. PichonB. YoungB. WilsonD.J. LlewelynM.J. PaulJ. PetoT.E.A. CrookD.W. WalkerA.S. GolubchikT. Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing.J. Clin. Microbiol.20145241182119110.1128/JCM.03117‑1324501024
     [Google Scholar]
  74. McDermottP.F. TysonG.H. KaberaC. ChenY. LiC. FolsterJ.P. AyersS.L. LamC. TateH.P. ZhaoS. Whole-genome sequencing for detecting antimicrobial resistance in nontyphoidal Salmonella.Antimicrob. Agents Chemother.20166095515552010.1128/AAC.01030‑1627381390
     [Google Scholar]
  75. SutradharI. ChingC. DesaiD. SuprenantM. BriarsE. HeinsZ. KhalilA.S. ZamanM.H. Computational model to quantify the growth of antibiotic-resistant bacteria in wastewater.mSystems202163e00360-2110.1128/mSystems.00360‑2134100640
     [Google Scholar]
  76. CampV.P.J. HaslamD.B. PorolloA. Porollo AJIjoms. Bioinformatics approaches to the understanding of molecular mechanisms in antimicrobial resistance.Int. J. Mol. Sci.2020214136310.3390/ijms2104136332085478
     [Google Scholar]
  77. DarbandiA. AbdiM. DashtbinS. YaghoubiS. SholehM. KouhsariE. DarbandiT. GhanavatiR. TaheriB. Antibody–antibiotic conjugates: A comprehensive review on their therapeutic potentials against bacterialinfections.J. Clin. Lab. Anal.20243810e2507110.1002/jcla.2507138867639
     [Google Scholar]
  78. VitielloA. RezzaG. SilenziA. SalzanoA. AliseM. BoccellinoM.R. PonzoA. ZoviA. SabbatucciM. Therapeutic strategies to combat increasing rates of multidrug resistant pathogens.Pharm. Res.20244181557157110.1007/s11095‑024‑03756‑539107513
     [Google Scholar]
  79. El-KafrawyS.A. AbbasA.T. OelkrugC. TahoonM. EzzatS. ZumlaA. AzharE.I. IgY antibodies: The promising potential to overcome antibiotic resistance.Front. Immunol.202314106535310.3389/fimmu.2023.106535336742328
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882352704250127093311
Loading
Antimicrobial Resistance: Challenges and Innovative Solutions
NEW Emirates Medical J 5, E02506882352704 (2024); https://doi.org/10.2174/0102506882352704250127093311
/content/journals/nemj/10.2174/0102506882352704250127093311
/content/journals/nemj/10.2174/0102506882352704250127093311
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Antimicrobial resistance; Antimicrobial stewardship; COVID-19; Mechanisms of resistance; Public health; Therapeutic approaches

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test